On Tuesday afternoon, 23rd May, pharmaphorum headed over to The Royal Society of Medicine to learn more about how the pharmaceutical industry goes about securing market access to medicines
The PM Society, which supports companies and individuals working in pharma marketing and healthcare communications, has created a new Industry Council and expanded its Board of Directors.
The PM Society Market Access Interest Group (MAIG) is gearing up to host its next in-person meeting on Tuesday, May 23rd, at the prestigious Royal Society of Medicine in London.
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.